Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 11/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9980862 | 0.91 | PDE10A (0.55) | PDE10AALDH1A1 | |
| SCHEMBL9981982 | 0.90 | PDE10A (0.45) | PDE10AKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL10039758 | 0.89 | PDE10A (0.55) | PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL12045863 | 0.88 | PDE10A (0.60) | PDE10AKDM4EALDH1A1HPGDCRHR1 | |
| SCHEMBL12060224 | 0.88 | PDE10A (0.51) | PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL12060213 | 0.87 | PDE10A (0.66) | PDE10AKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL9981118 | 0.87 | PDE10A (0.53) | PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL9981254 | 0.87 | PDE10A (0.53) | PDE10AKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL9980868 | 0.86 | PDE10A (0.60) | PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL9980983 | 0.85 | PDE10A (0.41) | PDE10AKDM4EALDH1A1HPGDCRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797963-B1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-03 | — | — | EP | claimed |
| US-9601231-B2 | Hyperbranched olefin oil-based dielectric fluid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-03-21 | — | — | US | claimed |
| US-9522855-B2 | Process for producing low molecular weight ethylene- and alpha-olefin-based materials | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-20 | — | — | US | claimed |
| EP-2797962-B1 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT ETHYLENE- AND ALPHA-OLEFIN-BASED MATERIALS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-11-18 | — | — | EP | claimed |
| US-20140357918-A1 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT ETHYLENE- AND ALPHA-OLEFIN-BASED MATERIALS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-12-04 | — | — | US | claimed |
| US-20140330056-A1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-11-06 | — | — | US | claimed |
| US-11155738-B2 | Branched triglyceride-based fluids useful for dielectric and/or heat transfer applications | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200115606-A1 | Branched Triglyceride-Based Fluids Useful for Dielectric and/or Heat Transfer Applications | DOW GLOBAL TECHNOLOGIES LLC | 2020-04-16 | — | — | US | disclosed |
| EP-3209744-B1 | ELECTRICAL DEVICES COMPRISING DIELECTRIC FLUIDS BASED ON BRANCHED TRIGLYCERIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-31 | — | — | EP | disclosed |
| EP-2797963-B1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-03 | — | — | EP | disclosed |
| US-20170349800-A1 | Branched Triglyceride-Based Fluids Useful for Dielectric and/or Heat Transfer Applications | DOW GLOBAL TECHNOLOGIES LLC | 2017-12-07 | — | — | US | disclosed |
| US-9601231-B2 | Hyperbranched olefin oil-based dielectric fluid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-03-21 | — | — | US | disclosed |
| US-9601231-B2 | Hyperbranched olefin oil-based dielectric fluid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-03-21 | — | — | US | disclosed |
| US-8563575-B2 | Fused heterocyclic compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-10-22 | — | — | US | disclosed |
| US-8563575-B2 | Fused heterocyclic compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-10-22 | — | — | US | disclosed |
| WO-2013101376-A1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-04 | — | — | WO | disclosed |
| US-20130172328-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS | CROSSWING INC. (CA) | 2013-07-04 | — | — | US | disclosed |
| US-20130172328-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS | CROSSWING INC. (CA) | 2013-07-04 | — | — | US | disclosed |
| US-20110319394-A1 | FUSED HETEROCYCLIC COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110319394-A1 | FUSED HETEROCYCLIC COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357918-A1 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT ETHYLENE- AND ALPHA-OLEFIN-BASED MATERIALS | EEF1D, EPN1, ELOC | PDE10A 4787/4885KDM4E 2288/4885ALDH1A1 4014/4885 |
| US-20130172328-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS | PDE3A, PDE5A, PDE2A | PDE10A 13/4885KDM4E 1979/4885ALDH1A1 166/4885 |
| US-20110319394-A1 | FUSED HETEROCYCLIC COMPOUNDS | PDE5A, PDE2A, PDE3A | PDE10A 12/4885KDM4E 896/4885ALDH1A1 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.